Anderson-Fabry disease (AFD) cardiomyopathy is characterized by glycosphingolipid (Gb3)
storage in all cellular components, with consequent left ventricular hypertrophy (LVH). Gb3 …

Background The prognostic value of different grades of left ventricular hypertrophy (LVH)
and left ventricular (LV) mechanical function in Fabry disease is unclear. We aimed to …

Introduction Fabry disease is a rare X-linked genetic disorder in which cardiac
manifestations include LVH, contractile dysfunction, and fibrosis, visible on cardiac MRI …

Magnetic resonance (MR) imaging is a useful and noninvasive modality for evaluation of the
cardiovascular anatomy, characteristics of myocardial tissue, and myocardial metabolism …

Fabry cardiomyopathy (FC) is characterized by left ventricular hypertrophy (LVH). The aim of
this study is to determine whether early changes revealed by tissue Doppler imaging (TDI) …

Background Fabry disease (FD) is a rare X‐linked storage disorder caused by deficiency of
the lysosomal enzyme α‐galactosidase A, and it typically causes multiorgan dysfunction …

Background There is limited evidence on the risk stratification of cardiovascular outcomes in
patients with Fabry disease (FD). Objectives This study sought to classify FD patients into …

Tissue Doppler and deformation imaging, including Doppler-derived strain and speckle
tracking, have significantly improved our understanding of cardiac mechanics in both …

Background Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) are two diseases
with a different pathophysiology, both cause left ventricular hypertrophy (LVH) and …

Fabry disease (FD) is a systemic lysosomal storage disorder caused by a deficiency of the
enzyme a-galactosidase A. Cardiac involvement, mainly characterized by left ventricular …